// App-Quantinova.ai

: Hypofibrinogenemia in Patient with Extended Exposure to Argatroban Therapy

Researchers

Presenter

  • Mustafa Saudi

Principal Investigators

  • N/A

Medical Centers

  • Elmhurst Hospital Center, Icah School of Medicine, elmhurst, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Autoimmune (AI)

Disease

  • Deep vein thrombosis

  • Pulmonary embolism

  • Venous thrombosis

  • Dyspnea

  • Asthma

Biomarkers

  • Alanine transaminase

  • Anaplastic lymphoma Kinase

  • Aspartate aminotransferase

  • Cytoglobin

  • Fibrinogen

  • Lactate

  • Serotonin

  • White Blood Cell

  • Activated partial thromboplastin time

  • Platelet count

  • Bilirubin

Drug/Treatment

  • Tenecteplase

  • Epinephrine

  • Adrenaclick

  • Alprazolam

  • Argatroban

  • Fibrinogen (IV)

  • Carbocysteine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A